James Simon, M.D., clinical professor of obstetrics and gynecology, was mentioned in an article in Healio's Endocrine Today on his study finding Flibanserin, a serotonin receptor 1A agonist/serotonin receptor 2A antagonist, safely and effectively improved the sexual interactions of naturally postmenopausal women diagnosed with hypoactive sexual desire disorder.
Healio - Serotonin Receptor Shows Promise in Hypoactive Sexual Desire Disorder
Latest News
Basil Considine, a third-year medical student at the George Washington University School of Medicine and Health Sciences (GW SMHS), addressed U.S. Food and Drug Administration (FDA) leadership, pharmaceutical representatives, and association stakeholders during a public meeting regarding the…
The George Washington University School of Medicine and Health Sciences (SMHS) recently honored a pair of accomplished faculty members, Sharad Goyal, MD, and Christina M. Puchalski, MD ’94, RESD ’97, for their academic excellence and leadership in patient care by formally bestowing them with…
The GW Department of Dermatology has been awarded a prestigious Competitive Clinical Research Grant by Eli Lilly and Company to evaluate the effectiveness of Atopic Triad (atopic dermatitis, asthma, and seasonal allergies) screening and education to reduce the burden of Atopic Dermatitis and its…